JUSTIN KURTZ: Open Payments
NPI 1427619527 · LIVERPOOL, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,978 in 68 payments from 21 companies in 2025. Trend: 2023 $103 · 2024 $1,447 · 2025 $2,978
Food & beverage: $1,635Travel & lodging: $1,342
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 4 | $1,571 |
| Novartis Pharmaceuticals Corporation | 21 | $405 |
| Edwards Lifesciences Corporation | 4 | $185 |
| Amgen Inc. | 13 | $135 |
| Medtronic, Inc. | 1 | $133 |
| PFIZER INC. | 3 | $90 |
| Merck Sharp & Dohme LLC | 3 | $57 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $49 |
| AstraZeneca Pharmaceuticals LP | 3 | $44 |
| Abbott Laboratories | 2 | $40 |
Products named: WATCHMAN Access System, LEQVIO, REPATHA, MICRA, VYNDAQEL, JARDIANCE, FARXIGA, NAVITOR.
Industry payments across NY — which companies pay providers there.
